These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27975209)

  • 1. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
    Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
    Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia.
    Craig CM; Liu LF; Nguyen T; Price C; Bingham J; McLaughlin TL
    Diabetes Obes Metab; 2018 Feb; 20(2):352-361. PubMed ID: 28776922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass - a systematic review.
    Jalleh RJ; Umapathysivam MM; Plummer MP; Deane A; Jones KL; Horowitz M
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1075-1088. PubMed ID: 37439960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.
    Honka H; Gastaldelli A; Pezzica S; Peterson R; DeFronzo R; Salehi M
    Diabetes Obes Metab; 2024 Jun; 26(6):2476-2486. PubMed ID: 38558527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
    Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
    Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Hormonal Response to a Mixed-Meal Challenge in Hypoglycemia After Sleeve Gastrectomy vs Gastric Bypass.
    Lee CJ; Clark JM; Egan JM; Carlson OD; Schweitzer M; Langan S; Brown T
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4159-e4166. PubMed ID: 35914520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
    Mulla CM; Goldfine AB; Dreyfuss JM; Houten S; Pan H; Pober DM; Wewer Albrechtsen NJ; Svane MS; Schmidt JB; Holst JJ; Craig CM; McLaughlin TL; Patti ME
    Obes Surg; 2019 Jul; 29(7):2092-2099. PubMed ID: 30976983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; Naver L; Madsbad S; Holst JJ
    Diabetes; 2013 Sep; 62(9):3044-52. PubMed ID: 23649520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia.
    Lobato CB; Pereira SS; Guimarães M; Hartmann B; Wewer Albrechtsen NJ; Hilsted L; Holst JJ; Nora M; Monteiro MP
    Front Endocrinol (Lausanne); 2020; 11():608248. PubMed ID: 33424773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
    Salehi M; Gastaldelli A; D'Alessio DA
    Gastroenterology; 2014 Mar; 146(3):669-680.e2. PubMed ID: 24315990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
    Roberts GP; Kay RG; Howard J; Hardwick RH; Reimann F; Gribble FM
    Surg Obes Relat Dis; 2018 May; 14(5):562-568. PubMed ID: 29548882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
    Guarino D; Moriconi D; Mari A; Rebelos E; Colligiani D; Baldi S; Anselmino M; Ferrannini E; Nannipieri M
    Diabetologia; 2019 Jan; 62(1):178-186. PubMed ID: 30315341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals.
    Tripyla A; Herzig D; Reverter-Branchat G; Pavan J; Schiavon M; Eugster PJ; Grouzmann E; Nakas CT; Sauvinet V; Meiller L; Zehetner J; Giachino D; Nett P; Gawinecka J; Del Favero S; Thomas A; Thevis M; Dalla Man C; Bally L
    Diabetologia; 2023 Apr; 66(4):741-753. PubMed ID: 36648553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for exogenous GLP-1 in the management of postprandial hypoglycaemia after Roux-en-Y gastric bypass?
    Øhrstrøm CC; Knop FK
    Eur J Endocrinol; 2019 Sep; 181(3):C5-C8. PubMed ID: 31370002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.
    Sterl K; Wang S; Oestricker L; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
    Peptides; 2016 Aug; 82():76-84. PubMed ID: 27288245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.